Oxygen binding to the oxygenase domain of reduced endothelial nitric oxide synthase (eNOS) results in two distinct species differing in their Soret and visible absorbance maxima and in their capacity to exchange oxygen by CO. At 7°C, heme-oxy I (with maxima at 420 and 560 nm) is formed very rapidly (k on Ϸ 2.5⅐10 6 M ؊1 ⅐s ؊1 ) in the absence of substrate but in the presence of pterin cofactor. It is capable of exchanging oxygen with CO at ؊30°C. Heme-oxy II is formed more slowly (k on Ϸ 3⅐10 5 M ؊1 ⅐s ؊1 ) in the presence of substrate, regardless of the presence of pterin. It is also formed in the absence of both substrate and pterin. In contrast to heme-oxy I, it cannot exchange oxygen with CO at cryogenic temperature. In the presence of arginine, heme-oxy II is characterized by absorbance maxima near 432, 564, and 597 nm. When arginine is replaced by N-hydroxyarginine, and also in the absence of both substrate and pterin, its absorbance maxima are blue-shifted to 428, 560, and 593 nm. Heme-oxy I seems to resemble the ferrous dioxygen complex observed in many hemoproteins, including cytochrome P450. Heme-oxy II, which is the oxygen complex competent for product formation, appears to represent a distinct conformation in which the electronic configuration is essentially locked in the ferric superoxide complex.Activation of molecular oxygen by nitric oxide synthase precedes NO 1 biosynthesis by a yet incompletely known reaction mechanism. A study of the steps following oxygen binding and NO formation is important since NO is a mediator of a wide range of physiological and pathophysiological processes in humans and other mammals (1-6). The formation of NO is catalyzed by nitric oxide synthases (NOS; EC 1.14.13.39) via a two-step mechanism. The substrate, L-Arg, is first converted to N G -hydroxy-L-Arg (NHA) at the heme active site. In the second step, NHA is further oxidized to NO and citrulline (3). In both steps, oxygen binding occurs after a one-electron reduction of the ferric heme. Prior to product formation, an electron stemming from tetrahydrobiopterin (BH4) then further reduces the ferrous oxygen complex.Despite much effort, the reaction mechanism of these steps is still unclear. Even the spectral properties of the oxyferrous complex are not yet defined; conflicting observations report absorbance maxima differing by up to 15 nm. The origin of these differences is unknown. The strongest differences are those between observations at cryogenic temperatures yielding maxima in the 417-419-nm region (7-9) and observations at higher temperatures by rapid scan techniques yielding considerably red-shifted maxima (430 -432 nm) (10 -14). However, this distinction is not clear-cut; in some cases, low wavelength maxima are also found by rapid scan spectroscopy (11), and high wavelength maxima are also found by low temperature UV-visible spectroscopy (9).To clarify this confusing situation, we reanalyzed the temporal evolution of the spectral changes occurring upon oxygen binding to reduced eNOS oxygenase domain by rapi...